Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 2/20 | 0.88 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.52 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.52 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.52 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.52 |
| ▸ | RARG | P13631 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.52 |
| ▸ | PPARA | Q07869 | 1/20 | 0.52 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.52 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fasidotril SCHEMBL7301419 | 1.00 | ACE (0.88) | ACEHRH4CYP3A4CYP1A2CYP2D6 | |
| Fasidotrilat SCHEMBL29595981 | 0.94 | ACE (1.00) | ACEHRH4CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL3081031 | 0.86 | ACE (0.66) | ACEHRH4CYP2D6TSHRALDH1A1 | |
| SCHEMBL3081041 | 0.86 | ACE (0.66) | ACEHRH4CYP2D6TSHRALDH1A1 | |
| SCHEMBL3081033 | 0.86 | ACE (0.66) | ACEHRH4CYP2D6TSHRALDH1A1 | |
| SCHEMBL8297852 | 0.83 | ACE (0.61) | ACEHRH4CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL5913510 | 0.78 | HRH4 (0.62) | ACEHRH4CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL5913277 | 0.78 | HRH4 (0.62) | ACEHRH4CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL8691873 | 0.78 | HRH4 (0.62) | ACEHRH4CYP3A4CYP1A2CYP2D6 | |
| SCHEMBL8167846 | 0.77 | CYP1A2 (0.61) | ACECYP3A4CYP1A2CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3706 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022265697-A1 | COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND METHODS FOR SAME | Tiger Development, LLC (US) | 2022-12-22 | — | — | WO | claimed |
| US-20220370360-A1 | COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND METHODS FOR SAME | ACCESS TO ADVANCED HEALTH INSTITUTE | 2022-11-24 | — | — | US | claimed |
| US-20210401751-A1 | COMPOSITIONS FOR TREATING VIRAL INFECTIONS AND METHODS FOR SAME | Tiger Development Inc. (US) | 2021-12-30 | — | — | US | claimed |
| US-11166956-B2 | Combinations of PDE1 inhibitors and NEP inhibitors | INTRA-CELLULAR THERAPIES, INC. (US) | 2021-11-09 | — | — | US | claimed |
| US-20190275046-A1 | NOVEL COMBINATION | INTRA-CELLULAR THERAPIES, INC. (US) | 2019-09-12 | — | — | US | claimed |
| US-10285992-B2 | Combinations of PDE1 inhibitors and NEP inhibitors and associated methods | INTRA-CELLULAR THERAPIES, INC. (US) | 2019-05-14 | — | — | US | claimed |
| EP-2661431-B1 | HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK | BIOENERGENIX (US) | 2018-07-11 | — | — | EP | claimed |
| US-20180118773-A1 | CRYSTALLINE FORM OF BENZYLBENZENE SGLT2 INHIBITOR | THERACOSBIO, LLC | 2018-05-03 | — | — | US | claimed |
| EP-2150526-B1 | N-ADAMANTYL BENZAMIDES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE | VTV THERAPEUTICS LLC (US) | 2017-09-20 | — | — | EP | claimed |
| CN-106466481-A | Sartans and NEPi complex | 叶莉 | 2017-03-01 | — | — | CN | claimed |
| US-20040192584-A1 | Combination of an aldosterone receptor antagonist and a neutral endopeptidase inhibitor | PHARMACIA CORPORATION | 2004-09-30 | — | — | US | claimed |
| EP-1413315-A1 | SUSTAINED-RELEASE MEDICINES | Takeda Chemical Industries, Ltd. (JP) | 2004-04-28 | — | — | EP | claimed |
| EP-1397160-A1 | PHARMACEUTICAL COMPOSITION INCLUDING ACE/NEP INHIBITORS AND BIOAVAILABILITY ENHANCERS | Shire Laboratories Inc. (US) | 2004-03-17 | — | — | EP | claimed |
| WO-2003091207-A2 | METHOD OF PREPARING AMINE STEREOISOMERS | APSINTERM, LLC. (US) | 2003-11-06 | — | — | WO | claimed |
| US-20030096761-A1 | Pharmaceutical compositions including ACE/NEP inhibitors and bioavailability enhancers | SHIRE BIOCHEM INC. (CA) | 2003-05-22 | — | — | US | claimed |
| WO-2002087621-A1 | PHARMACEUTICAL COMPOSITION INCLUDING ACE/NEP INHIBITORS AND BIOAVAILABILITY ENHANCERS | SHIRE LABORATORIES INC. (US) | 2002-11-07 | — | — | WO | claimed |
| US-20020055645-A1 | Process for synthesizing N-(mercaptoacyl) amino acid derivatives from alpha-substituted acrylic acids | BIOPROJET (FR) | 2002-05-09 | — | — | US | claimed |
| CN-1310623-A | Biological implant formulation | PEPTECH LTD (AU) | 2001-08-29 | — | — | CN | claimed |
| EP-1104296-A1 | BIOIMPLANT FORMULATION | PEPTECH LIMITED (AU) | 2001-06-06 | — | — | EP | claimed |
| WO-2000004897-A1 | BIOIMPLANT FORMULATION | PEPTECH LIMITED (AU) | 2000-02-03 | — | — | WO | claimed |